Mga Batayang Estadistika
| LEI | 549300X2FQ6S98OQLQ46 |
| CIK | 353569 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to QuidelOrtho Corporation
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| June 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-10961 QUIDEL CORPORATION (Exact name of registrant as specified in its |
|
| May 26, 2022 |
SD 1 qdelformsd2021.htm SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report QUIDEL CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 0-10961 94-2573850 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 9975 Summers Ridge Road, San Diego CA 92121 (Address of Pri |
|
| May 26, 2022 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of Form SD. Exhibit 1.01 CONFLICT MINERALS REPORT For The Year Ended December 31, 2021 Introduction This Conflict Minerals Report (?Report?) of Quidel Corporation for the year ended December 31, 2021 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as amended (?Rule?). Numerous terms in this Report are defined in Item 1.01 of Form SD promulgated under the Rule, and the reader |
|
| May 16, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 16, 2022 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2022 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2022 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 5, 2022 |
QDEL / Quidel Corporation / Senvest Management, LLC - QUIDEL CORPORATION Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Quidel Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 74838J101 (CUSIP Number) April 28, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| May 5, 2022 |
Event Type: Q1 2022 Earnings Call Date: 2022-05-04 Company: Quidel Corp. Ticker: QDEL COMPANY PARTICIPANTS Ruben Argueta - Quidel Corp., Director-Investor Relations Douglas C. Bryant - Quidel Corp., President, Chief Executive Officer & Director Randall J. Steward - Quidel Corp., Chief Financial Officer OTHER PARTICIPANTS Jack Meehan - Analyst Andrew Cooper - Analyst MANAGEMENT DISCUSSION SECTION O |
|
| May 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-10961 QUIDEL CORP |
|
| May 4, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 4, 2022 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 4, 2022 |
Filed by Quidel Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Ortho Clinical Diagnostics Holdings plc (Commission File No. |
|
| May 4, 2022 |
QUIDEL REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] QUIDEL REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS SAN DIEGO, CA ? May 4, 2022 ? Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and mole |
|
| April 11, 2022 |
DEFM14A 1 d273090ddefm14a.htm DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as p |
|
| April 7, 2022 |
QUIDEL ANNOUNCES PRELIMINARY REVENUE FOR FIRST QUARTER 2022 Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] QUIDEL ANNOUNCES PRELIMINARY REVENUE FOR FIRST QUARTER 2022 SAN DIEGO ? (BUSINESS WIRE)?April 7, 2022?Quidel Corporation (NASDAQ: QDEL) (?Quidel?), a provider of rapid diagnostic testing solutions, cellular |
|
| April 7, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 7, 2022 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Num |
|
| March 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from N/A to N/A Commission file number |
|
| March 11, 2022 |
Exhibit 10.40 November 12, 2020 Michelle Hodges 5831 Country View Drive Yorba Linda, CA 92866 Dear Michelle: We are pleased to extend the following offer of employment to you: Title: Senior Vice President, General Counsel Reporting to: Doug Bryant ? President & CEO Compensation: $15,000.00 bi-weekly ($390,000 annualized) Annual Bonus: You will participate in our bonus plan with a target bonus of 7 |
|
| February 18, 2022 |
Subsidiaries of the Registrant. Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT Company State or Country of Organization Diagnostic Hybrids, Inc. Ohio Quidel Cardiovascular Inc. Delaware Quidel Ireland Limited Ireland Quidel China Ltd. China |
|
| February 18, 2022 |
Exhibit 10.32 TRANSITION AGREEMENT AND RELEASE THIS TRANSITION AGREEMENT AND RELEASE (this ?Agreement?) is made and entered as of November 2021 by and between QUIDEL CORPORATION, a Delaware corporation (the ?Company?), and Karen Gibson, an individual (?Gibson?). BACKGROUND A.Karen Gibson currently serves as the SVP, Digital Health and intends to retire from this current role and transition to the |
|
| February 18, 2022 |
10-K for the year ended December 31, 2021.) Exhibit 10.34 AGREEMENT RE: CHANGE IN CONTROL This AGREEMENT RE: CHANGE IN CONTROL (this ?Agreement?) is dated as of and is entered into by and between EXECUTIVE NAME (?Executive?) and Quidel Corporation, a Delaware corporation (the ?Company?). Background The Company believes that because of its position in the industry, financial resources and historical operating results there is a possibility t |
|
| February 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from N/A to N/A Commission file number: 0-10961 QUIDEL C |
|
| February 18, 2022 |
425 1 qdelq4earningscalltransc.htm 425 Event Type: Q4 2021 Earnings Call Date: 2022-02-17 Company: Quidel Corp. Ticker: QDEL COMPANY PARTICIPANTS Ruben Argueta - Quidel Corp., Director-Investor Relations Douglas C. Bryant - Quidel Corp., President, Chief Executive Officer & Director Randall J. Steward - Quidel Corp., Chief Financial Officer Unverified Participant OTHER PARTICIPANTS MANAGEMENT DISC |
|
| February 18, 2022 |
Amendment to Individual Retirement Program for Randall Steward, dated February 1, 2022. Exhibit 10.39 AMENDMENT TO QUIDEL CORPORATION INDIVIDUAL RETIREMENT PROGRAM FOR RANDY STEWARD This Amendment (this ?Amendment?) to the Quidel Corporation Individual Retirement Program for Randy Steward by and between Randall Steward (?Employee?) and Quidel Corporation (the ?Company?) is made effective as of February 1, 2022 by and between the Company and Employee (collectively, the ?Parties?). REC |
|
| February 17, 2022 |
425 1 a425qdel202112318k991.htm 425 Filed by Quidel Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Ortho Clinical Diagnostics Holdings plc (Commission File No. 001-39956) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT |
|
| February 17, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 17, 2022 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| February 17, 2022 |
QUIDEL REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] QUIDEL REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS SAN DIEGO, CA ? February 17, 2022 ? Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based vir |
|
| February 14, 2022 |
425 1 d310290d425.htm 425 Filed by Quidel Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Ortho Clinical Diagnostics Holdings plc (Commission File No. 001-39956) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PU |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 9, 2022 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| February 14, 2022 |
QDEL / Quidel Corporation / BROWN CAPITAL MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 12)* Quidel Corporation (Name of Issuer) Common Stock, Par Value $0.001 (Title of Class of Securities) 74838J101 (CUSIP Number) Eddie C. Brown Brown Capital M |
|
| February 14, 2022 |
QDEL / Quidel Corporation / ALGER ASSOCIATES INC - QUIDEL CORPORATION Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Quidel Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 74838J101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 10, 2022 |
QDEL / Quidel Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Quidel Corp. Title of Class of Securities: Common Stock CUSIP Number: 74838J101 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Rule 1 |
|
| February 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 31, 2022 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| February 4, 2022 |
425 1 a425-8xk02x04x2022.htm 425 Filed by Quidel Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Ortho Clinical Diagnostics Holdings plc (Commission File No. 001-39956) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT RE |
|
| February 4, 2022 |
Exhibit 10.1 2022 Cash Incentive Compensation Plan Eligible Employees: All executive officers, senior vice presidents and vice presidents of the Company are eligible for participation in the Company?s 2022 Cash Incentive Compensation Plan. Applicable Period: The 2022 Cash Incentive Plan applies to performance during the Company?s fiscal year ending December 31, 2022. In 2022, goals will be establi |
|
| February 4, 2022 |
Exhibit 10.2 2022 Annual Equity Incentive Plan The 2022 Annual Equity Incentive Plan provides for the issuance of equity incentive awards in the form of (i) non-qualified stock options; and (ii) time-based restricted stock units. Executive Officer Time-Based Restricted Stock Units (# shares) Non-Qualified Stock Options (# shares) Douglas C. Bryant President & Chief Financial Officer 27,043 27,043 |
|
| February 4, 2022 |
[Quidel Letterhead] Exhibit 10.4 [Form of Integration/Retention Cash/Equity Bonus Award Letter] February 1, 2022 To: EMPLOYEE From: Doug Bryant Given the importance of our integration efforts related to our acquisition of Ortho Clinical Diagnostics, we have implemented a bonus program to recognize the extraordinary efforts a transaction of this magnitude will entail. Your bonus target is % of your |
|
| February 4, 2022 |
[Quidel Letterhead] Exhibit 10.3 [Form of Success Fee Letter] February 1, 2022 To: EMPLOYEE From: Doug Bryant Given the importance of our efforts to consummate our acquisition of Ortho Clinical Diagnostics, we have implemented a success fee bonus program to recognize the extraordinary efforts a transaction of this magnitude will entail. Your bonus target is 100% of your base salary that is current |
|
| January 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 22, 2022 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| January 18, 2022 |
425 1 d248329d425.htm 425 Filed by Ortho Clinical Diagnostics Holdings plc Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company: Quidel Corporation (Commission File No.: 000-10961) Date: January 18, 2022 Table of Contents Overview 3 Key Messages 4 Communications Plan 5 Documents 6 Ortho |
|
| January 12, 2022 |
Filed by Quidel Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Ortho Clinical Diagnostics Holdings plc (Commission File No. |
|
| January 12, 2022 |
Filed by Quidel Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Ortho Clinical Diagnostics Holdings plc (Commission File No. |
|
| January 6, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 6, 2022 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File N |
|
| January 6, 2022 |
Filed by Quidel Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Ortho Clinical Diagnostics Holdings plc (Commission File No. |
|
| January 6, 2022 |
Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] QUIDEL ANNOUNCES PRELIMINARY REVENUE FOR FOURTH QUARTER 2021; QUIDEL TO PRESENT VIRTUALLY AT 40th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE SAN DIEGO ? (BUSINESS WIRE)?January 6, 2022?Quidel Corporation (NAS |
|
| December 27, 2021 |
Filed by Ortho Clinical Diagnostics Holdings plc Filed by Ortho Clinical Diagnostics Holdings plc Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Quidel Corporation Commission File No.: 000-10961 Date: December 23, 2021 |
|
| December 27, 2021 |
Filed by Ortho Clinical Holdings plc Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Quidel Corporation Commission File No. |
|
| December 27, 2021 |
Filed by Ortho Clinical Diagnostics Holdings plc Filed by Ortho Clinical Diagnostics Holdings plc Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Quidel Corporation Commission File No. |
|
| December 27, 2021 |
Translations of this message will be available on Inside Ortho shortly 425 1 d248329d425.htm 425 Filed by Ortho Clinical Holdings plc Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Quidel Corporation Commission File No.: 000-10961 Date: December 23, 2021 DECEMBER 23, 2021 Important Message from CEO Chris Smith Translations of this message will be available on In |
|
| December 27, 2021 |
Quidel | Ortho Frequently Asked Questions 425 1 d248329d425.htm 425 Filed by Ortho Clinical Diagnostics Holdings plc Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Quidel Corporation Commission File No.: 000-10961 Date: December 23, 2021 Quidel | Ortho Frequently Asked Questions We remain committed to providing you with timely acquis |
|
| December 27, 2021 |
Filed by Ortho Clinical Diagnostics Holdings plc 425 1 d248329d425.htm 425 Filed by Ortho Clinical Diagnostics Holdings plc Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Quidel Corporation Commission File No.: 000-10961 Date: December 23, 2021 |
|
| December 23, 2021 |
425 1 d262906d425.htm 425 Filed by Quidel Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Ortho Clinical Diagnostics Holdings plc (Commission File No. 001-39956) The following is a transcript of the conference call held on December 23, 2021 at 8:30 a.m. Easter |
|
| December 23, 2021 |
Filed by Quidel Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Ortho Clinical Diagnostics Holdings plc (Commission File No. |
|
| December 23, 2021 |
Exhibit 2.1 BUSINESS COMBINATION AGREEMENT by and among QUIDEL CORPORATION, CORONADO TOPCO, INC., ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC, LAGUNA MERGER SUB, INC., ORCA HOLDCO, INC. and ORCA HOLDCO 2, INC. Dated as of December 22, 2021 TABLE OF CONTENTS ARTICLE I THE COMBINATIONS Section 1.1. The Combinations 3 Section 1.2. Closing 4 Section 1.3. Effective Time 5 Section 1.4. Effect of the Orca Sc |
|
| December 23, 2021 |
Exhibit 10.1 PRINCIPAL STOCKHOLDERS AGREEMENT BY AND AMONG CORONADO TOPCO, INC., QUIDEL CORPORATION, ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC AND THE INITIAL CARLYLE STOCKHOLDER DECEMBER 22, 2021 TABLE OF CONTENTS Page SECTION I. DEFINITIONS 1 1.1 DraftingConventions; No Construction Against Drafter 1 1.2 Defined Terms 2 SECTION II. REPRESENTATIONS AND WARRANTIES AND COVENANTS 4 2.1 Representations |
|
| December 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 22, 2021 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| December 23, 2021 |
Filed by Quidel Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Ortho Clinical Diagnostics Holdings plc (Commission File No. |
|
| December 23, 2021 |
Filed by Quidel Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended, and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934, as amended Subject Company: Ortho Clinical Diagnostics Holdings plc (Commission File No. |
|
| December 23, 2021 |
Exhibit 99.1 Quidel Contacts: Ortho Clinical Diagnostics: Randy Steward Chief Financial Officer (858) 552-7931 Investors: Bryan Brokmeier, CFA [email protected] Media and Investors: Ruben Argueta (858) 646-8023 [email protected] Media: Lisa Hayes [email protected] Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics Strategic, transfo |
|
| December 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 22, 2021 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| November 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-10961 QUIDEL |
|
| November 4, 2021 |
QUIDEL REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858. |
|
| November 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 4, 2021 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| October 7, 2021 |
QUIDEL ANNOUNCES PRELIMINARY REVENUE FOR FISCAL THIRD QUARTER 2021 Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] QUIDEL ANNOUNCES PRELIMINARY REVENUE FOR FISCAL THIRD QUARTER 2021 SAN DIEGO, Ca ? (BUSINESS WIRE)?October 7, 2021?Quidel Corporation (NASDAQ: QDEL) (?Quidel?), a provider of rapid diagnostic testing soluti |
|
| October 7, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 7, 2021 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File N |
|
| August 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-10961 QUIDEL CORPO |
|
| August 5, 2021 |
QUIDEL REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858. |
|
| August 5, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 5, 2021 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| July 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 24, 2021 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Num |
|
| July 26, 2021 |
Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer (858) 646-8023 (858) 552-7931 [email protected] QUIDEL ANNOUNCES AGREEMENT WITH BECKMAN COULTER THAT TERMINATES ONGOING LITIGATION AND TRANSITIONS BNP BUSINESS TO BECKMAN COULTER ? Settlement Agreement ends litigation that began in November 2017, fol |
|
| July 26, 2021 |
Exhibit 10.1 CERTAIN INFORMATION OF THIS EXHIBIT (IDENTIFIED BY ?[***]?) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL. EXECUTION VERSION MASTER AGREEMENT This MASTER AGREEMENT (this ?Agreement?), dated as of July 24, 2021 (?Effective Date?), is entered into by and among Quidel Corporation, a Delaware corporati |
|
| June 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report QUIDEL CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 0-10961 94-2573850 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 9975 Summers Ridge Road, San Diego CA 92121 (Address of Principal Executive Offices) ( |
|
| June 1, 2021 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of Form SD. Exhibit 1.01 CONFLICT MINERALS REPORT For The Year Ended December 31, 2020 Introduction This Conflict Minerals Report (?Report?) of Quidel Corporation for the year ended December 31, 2020 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as amended (?Rule?). Numerous terms in this Report are defined in Item 1.01 of Form SD promulgated under the Rule, and the reader |
|
| May 19, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 18, 2021 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 7, 2021 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 12, 2021 |
Amendment No. 2 to Amended and Restated Credit Agreement Exhibit 10.1 AMENDMENT NO. 2 TO AMENDED AND RESTATED CREDIT AGREEMENT This AMENDMENT NO. 2 TO AMENDED AND RESTATED CREDIT AGREEMENT dated as of May 7, 2021 (this ?Amendment?), is entered into by and among QUIDEL CORPORATION, a Delaware corporation (the ?Borrower?), the Guarantors (as identified on the signature pages hereto, and together with the Borrower, the ?Loan Parties?), the Lenders party he |
|
| May 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-10961 QUIDEL CORP |
|
| May 6, 2021 |
QUIDEL REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858. |
|
| May 6, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2021 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| April 22, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 22, 2021 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| April 22, 2021 |
Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] QUIDEL ANNOUNCES PRELIMINARY REVENUE FOR FIRST QUARTER 2021 Establishes distribution partnership agreement with McKesson to increase access to At-Home COVID-19 testing SAN DIEGO-(BUSINESS WIRE)?Apr 22, 2021 |
|
| April 15, 2021 |
DEF 14A 1 a2020def14-a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as per |
|
| March 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 26, 2021 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| February 19, 2021 |
Exhibit 10.43 LEASE AGREEMENT by and between ARE-SD REGION NO. 71, LLC, a Delaware limited liability company, as Landlord and QUIDEL CORPORATION, a Delaware corporation, as Tenant Dated as of January 14, 2021 739237752.8 LEASE AGREEMENT THIS LEASE AGREEMENT (this ?Lease?) is made as of January 14, 2021 (the ?Effective Date?), by and between ARE-SD REGION NO. 71, LLC, a Delaware limited liability c |
|
| February 19, 2021 |
Subsidiaries of the Registrant. Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT Company State or Country of Organization Diagnostic Hybrids, Inc. Ohio Quidel Cardiovascular Inc. Delaware Quidel Ireland Limited Ireland Quidel China Ltd. China |
|
| February 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from N/A to N/A Commission file number: 0-10961 QUIDEL C |
|
| February 18, 2021 |
QUIDEL REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858. |
|
| February 18, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 18, 2021 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Amendment No. 18* (EXIT FILING) Under the Securities Exchange Act of 1934 Quidel Corp (Name of Issuer) Common Stock (Title of Class of Securities) 74838J101 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t |
|
| February 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 11)* Quidel Corporation (Name of Issuer) Common Stock, Par Value $0.001 (Title of Class of Securities) 74838J101 (CUSIP Number) Eddie C. Brown Brown Capital M |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: Quidel Corp. Title of Class of Securities: Common Stock CUSIP Number: 74838J101 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1 |
|
| February 5, 2021 |
2021 Annual Equity Incentive Plan Grants to the Company's Executive Officers. Exhibit 10.2 2021 Annual Equity Incentive Plan The 2021 Annual Equity Incentive Plan provides for the issuance of equity incentive awards in the form of (i) non-qualified stock options; (ii) time-based restricted stock units; and (iii) performance-based restricted stock units for the CEO and (i) non-qualified stock options and (ii) time-based restricted stock units for other executives. CEO: Execu |
|
| February 5, 2021 |
2021 Cash Incentive Compensation Plan. Exhibit 10.1 2021 Cash Incentive Compensation Plan Eligible Employees: All executive officers, senior vice presidents and vice presidents of the Company are eligible for participation in the Company’s 2021 Cash Incentive Compensation Plan. Applicable Period: The 2021 Cash Incentive Plan applies to performance during the Company’s fiscal year ending December 31, 2021. Components of the Plan and Cri |
|
| February 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 1, 2021 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| January 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 7, 2021 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File N |
|
| January 7, 2021 |
EX-99 2 qdel-20210107exhibit991.htm EX-99 Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] QUIDEL ANNOUNCES PRELIMINARY REVENUE FOR FOURTH QUARTER 2020; WILL PRESENT VIRTUALLY AT 39th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE SAN DIEGO-(BUSINESS WIRE)—Jan |
|
| November 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2020 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| November 13, 2020 |
Form of Indemnification Agreement – Corporate Officer and/or Director Exhibit 10.1 INDEMNIFICATION AGREEMENT This Indemnification Agreement (this “Agreement”) is made as of this day of , 20 , by and between Quidel Corporation, a Delaware corporation (the “Company”) and (“Indemnitee”). RECITALS WHEREAS, the Board of Directors of the Company (the “Board of Directors”) has determined that in order to attract and retain qualified persons as directors and officers of the |
|
| November 13, 2020 |
Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF QUIDEL CORPORATION (As amended by the Board of Directors on November 9, 2020) ARTICLE I CORPORATE OFFICES SECTION 1.1 REGISTERED OFFICE The address of the registered office of Quidel Corporation (the “Corporation”) shall be 160 Greentree Drive, Suite 101, Dover, County of Kent, Delaware 19904. The name of the registered agent of the Corporation at such ad |
|
| October 30, 2020 |
Exhibit 10.2 AGREEMENT RE: CHANGE IN CONTROL This AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of October 22, 2020 and is entered into by and between Tammi Ranalli (“Officer”) and Quidel Corporation, a Delaware corporation (the “Company”). Background The Company believes that because of its position in the industry, financial resources and historical operating results there is a |
|
| October 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-10961 QUIDEL |
|
| October 30, 2020 |
Execution Version Exhibit 10.1 AMENDMENT NO. 1 TO AMENDED AND RESTATED CREDIT AGREEMENT This AMENDMENT NO. 1 TO AMENDED AND RESTATED CREDIT AGREEMENT dated as of September 11, 2020 (this “Amendment”), is entered into by and among QUIDEL CORPORATION, a Delaware corporation (the “Borrower”), the Guarantors (as identified on the signature pages hereto, and together with the Borrower, the “Loan Partie |
|
| October 30, 2020 |
Exhibit 10.3 AGREEMENT RE: CHANGE IN CONTROL This AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of October 22, 2020 and is entered into by and between William Ferenczy (“Officer”) and Quidel Corporation, a Delaware corporation (the “Company”). Background The Company believes that because of its position in the industry, financial resources and historical operating results there is |
|
| October 29, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 29, 2020 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| October 29, 2020 |
QUIDEL REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858. |
|
| October 1, 2020 |
Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] QUIDEL ANNOUNCES PRELIMINARY REVENUE FOR THIRD QUARTER 2020 VIRTUAL INVESTOR DAY TO BE HELD ON NOVEMBER 12TH SAN DIEGO-(BUSINESS WIRE)—Oct 1, 2020- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider o |
|
| October 1, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 1, 2020 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File N |
|
| September 17, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 11, 2020 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission Fil |
|
| September 1, 2020 |
Regulation FD Disclosure - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 28, 2020 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File N |
|
| August 26, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 24, 2020 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File N |
|
| August 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 3, 2020 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| July 31, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-10961 QUIDEL CORPO |
|
| July 31, 2020 |
Fourth Amendment to Single Tenant Absolute Net Lease. Exhibit 10.1 FOURTH AMENDMENT TO SINGLE TENANT ABSOLUTE NET LEASE THIS FOURTH AMENDMENT TO SINGLE TENANT ABSOLUTE NET LEASE (this Amendment”) is entered into as of this 27th day of July, 2020, by and between 10165 MCKELLAR COURT, L.P., a California limited partnership (“Landlord”), and QUIDEL CORPORATION, a Delaware corporation (“Tenant”). RECITALS A.WHEREAS, Landlord and Tenant are parties to tha |
|
| July 30, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 30, 2020 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Num |
|
| July 30, 2020 |
QUIDEL REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858. |
|
| July 6, 2020 |
QUIDEL ANNOUNCES PRELIMINARY REVENUE FOR SECOND QUARTER 2020 Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] QUIDEL ANNOUNCES PRELIMINARY REVENUE FOR SECOND QUARTER 2020 SAN DIEGO-(BUSINESS WIRE)-July 6, 2020- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular- |
|
| July 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 1, 2020 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| June 11, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 10, 2020 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Num |
|
| June 11, 2020 |
Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] QUIDEL ANNOUNCES JACK SCHULER WILL RETIRE FROM QUIDEL’S BOARD OF DIRECTORS Forward-Looking Statements SAN DIEGO-(BUSINESS WIRE)-JUNE 11, 2020-Quidel Corporation (NASDAQ: QDEL) ("Quidel"), a provider of rapi |
|
| June 10, 2020 |
QDEL / QUIDEL Corp. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SC 13G/A 1 fp0054474sc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 10)* Quidel Corporation (Name of Issuer) Common Stock, Par Value $0.001 (Title of Class of Securities) 74838J101 (CUSIP Number) |
|
| May 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report QUIDEL CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 0-10961 94-2573850 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 9975 Summers Ridge Road, San Diego CA 92121 (Address of Principal Executive Offices) ( |
|
| May 29, 2020 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of Form SD. Exhibit 1.01 CONFLICT MINERALS REPORT For The Year Ended December 31, 2019 Introduction This Conflict Minerals Report (“Report”) of Quidel Corporation for the year ended December 31, 2019 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as amended (“Rule”). Numerous terms in this Report are defined in Item 1.01 of Form SD promulgated under the Rule, and the reader |
|
| May 13, 2020 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 12, 2020 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-10961 QUIDEL CORP |
|
| May 6, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2020 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 6, 2020 |
QUIDEL REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858. |
|
| April 9, 2020 |
QDEL / QUIDEL Corp. DEF 14A - - DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Defin |
|
| February 14, 2020 |
QDEL / QUIDEL Corp. / BROWN CAPITAL MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 9)* Quidel Corporation (Name of Issuer) Common Stock, Par Value $0.001 (Title of Class of Securities) 74838J101 (CUSIP Number) Eddie C. Brown Brown Capital Ma |
|
| February 14, 2020 |
PACB / Pacific Biosciences of California, Inc. / FEINBERG LARRY N - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Amendment No. 17* Under the Securities Exchange Act of 1934 Quidel Corp (Name of Issuer) Common Stock (Title of Class of Securities) 69404D108 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i |
|
| February 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from N/A to N/A Commission file number: 0-10961 QUIDEL C |
|
| February 13, 2020 |
Subsidiaries of the Registrant. Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT Company State or Country of Organization Diagnostic Hybrids, Inc. Ohio Quidel Cardiovascular Inc. Delaware Quidel Ireland Limited Ireland Quidel China Ltd. China |
|
| February 13, 2020 |
EX-4.5 2 ex45.htm EXHIBIT 4.5 Description of Quidel Corporation’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 The following description of the material terms of the shares of Quidel Corporation registered under the Section 12 of the Securities Exchange Act of 1934, as amended, is only a summary and is subject to, and qualified in its entirety by reference to |
|
| February 12, 2020 |
QDEL / QUIDEL Corp. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: Quidel Corp Title of Class of Securities: Common Stock CUSIP Number: 74838J101 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13 |
|
| February 12, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 12, 2020 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| February 12, 2020 |
QUIDEL REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS Exhibit Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858. |
|
| February 5, 2020 |
Individual Retirement Program for Werner Kroll. Exhibit 10.3 February 4, 2020 Quidel Corporation Individual Retirement Program for Werner Kroll (“Employee”) Effective February 4, 2020 (“Effective Date”) This Individual Retirement Program (the “Program”) is awarded to Employee by the Board of Directors (the “Board”) of Quidel Corporation (the “Company”), on behalf of the Company, as an incentive for Employee to continue his employment with the C |
|
| February 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 03, 2020 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| February 5, 2020 |
Exhibit 10.1 2020 Cash Incentive Compensation Plan Eligible Employees: All non-Section 16 officers (“Vice Presidents”) and senior executives (Section 16) officers (“Executive Officers”) of the Company are eligible for participation in the Company’s 2020 Cash Incentive Compensation Plan. Applicable Period: The 2020 Cash Incentive Plan applies to performance during the Company’s fiscal year ending D |
|
| February 5, 2020 |
Exhibit 10.2 2020 Annual Equity Incentive Plan The 2020 Annual Equity Incentive Plan provides for the issuance of equity incentive awards in the form of (i) non-qualified stock options; (ii) time-based restricted stock units; and (iii) performance-based restricted stock units for the CEO and (i) non-qualified stock options and (ii) time-based restricted stock units for other executives. CEO: Execu |
|
| January 10, 2020 |
QUIDEL ANNOUNCES PRELIMINARY REVENUE FOR FOURTH QUARTER 2019 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858. |
|
| January 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 9, 2020 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File N |
|
| November 22, 2019 |
Exhibit 10.1 Quidel Corporation Individual Retirement Program for Randy Steward (“Employee”) Effective November 22, 2019 (“Effective Date”) This Individual Retirement Program (the “Program”) is awarded to Employee by the Board of Directors (the “Board”) of Quidel Corporation (the “Company”), on behalf of the Company, as an incentive for Employee to continue his employment with the Company as Chief |
|
| November 22, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 18, 2019 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| October 31, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-10961 QUIDEL |
|
| October 30, 2019 |
QUIDEL REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858. |
|
| October 30, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 30, 2019 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File |
|
| August 29, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 29, 2019 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File N |
|
| August 9, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-10961 QUIDEL CORPO |
|
| August 8, 2019 |
QUIDEL REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858. |
|
| August 8, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 8, 2019 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 24, 2019 |
8-K 1 a8-k2019x06x20.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 20, 2019 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (C |
|
| June 4, 2019 |
Exhibit 10.1 Exchange Agreement June 4, 2019 Quidel Corporation 12544 High Bluff Drive, Suite 200 San Diego, California 92130 Attn: Randall J. Steward Re: Exchange of 3.25% Convertible Senior Notes due 2020 for Common Stock Ladies and Gentlemen: The undersigned investor (the “Investor”), for itself and on behalf of the beneficial owners listed on Exhibit B.1 hereto (“Accounts”) for whom the Invest |
|
| June 4, 2019 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 4, 2019 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Number) 94-2573 |
|
| May 31, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report QUIDEL CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 0-10961 94-2573850 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 12544 High Bluff Drive, Suite 200, San Diego CA 92130 (Address of Principal Executive |
|
| May 31, 2019 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of Form SD. Exhibit 1.01 CONFLICT MINERALS REPORT For The Year Ended December 31, 2018 Introduction This Conflict Minerals Report (“Report”) of Quidel Corporation for the year ended December 31, 2018 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as amended (“Rule”). Numerous terms in this Report are defined in Item 1.01 of Form SD promulgated under the Rule, and the reader |
|
| May 21, 2019 |
QDEL / QUIDEL Corp. / SCHULER JACK W Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* QUIDEL CORPORATION (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 74838J101 (CUSIP Number) May 20, 2019 (Date of Event Which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to rep |
|
| May 16, 2019 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 14, 2019 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Number) 94-2573 |
|
| May 9, 2019 |
Exhibit 10.1 AGREEMENT RE: CHANGE IN CONTROL This AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of February 11, 2019 and is entered into by and between Karen Gibson (“Officer”) and Quidel Corporation, a Delaware corporation (the “Company”). Background The Company believes that because of its position in the industry, financial resources and historical operating results there is a |
|
| May 9, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-10961 QUIDEL CORP |
|
| May 8, 2019 |
QUIDEL REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858. |
|
| May 8, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 8, 2019 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Number) 94-25738 |
|
| April 11, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Defin |
|
| February 15, 2019 |
Exhibit 10.36 QUIDEL CORPORATION RESTRICTED STOCK UNIT AWARD GRANT NOTICE (2018 Equity Incentive Plan) Pursuant to Section 6.10 of the Quidel Corporation 2018 Equity Incentive Plan (the “Plan”), Quidel Corporation (the “Company”) hereby awards to you a Restricted Stock Unit Award covering the number of shares of the Company’s Common Stock set forth below (the “Award”). This Award will be evidenced |
|
| February 15, 2019 |
Exhibit 10.39 QUIDEL CORPORATION ID: 94-2573850 12544 High Bluff Drive, Suite 200 San Diego, CA 92130 Notice of Grant of Nonqualified Stock Options and Option Agreement Name Option Number: Address Plan: 2018 Effective , you have been granted a Nonqualified Stock Option to buy shares of Common Stock of Quidel Corporation (the “Company”) at $ per share, pursuant to Section 6.1 of the Quidel Corporat |
|
| February 15, 2019 |
Exhibit 10.38 QUIDEL CORPORATION RESTRICTED STOCK UNIT AWARD GRANT NOTICE (2018 Equity Incentive Plan) Pursuant to Section 6.10 of the Quidel Corporation 2018 Equity Incentive Plan (the “Plan”), Quidel Corporation (the “Company”) hereby awards to you a time-vested Restricted Stock Unit Award covering the number of shares of the Company’s Common Stock set forth below (the “Award”). This Award will |
|
| February 15, 2019 |
Subsidiaries of the Registrant. Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT Company State or Country of Organization Diagnostic Hybrids, Inc. Ohio Quidel Cardiovascular Inc. Delaware Quidel Ireland Limited Ireland |
|
| February 15, 2019 |
QDEL / QUIDEL Corp. 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from N/A to N/A Commission file number: 0-10961 QUIDEL C |
|
| February 15, 2019 |
Exhibit 10.37 QUIDEL CORPORATION RESTRICTED STOCK UNIT AWARD GRANT NOTICE (2018 Equity Incentive Plan) Pursuant to Section 6.10 of the Quidel Corporation 2018 Equity Incentive Plan (the “Plan”), Quidel Corporation (the “Company”) hereby awards to you a performance-based Restricted Stock Unit Award covering the number of shares of the Company’s Common Stock set forth below (the “Award”). This Award |
|
| February 15, 2019 |
Exhibit 10.40 QUIDEL CORPORATION RESTRICTED STOCK UNIT AWARD GRANT NOTICE (2018 Equity Incentive Plan) Pursuant to Section 6.10 of the Quidel Corporation 2018 Equity Incentive Plan (the “Plan”) and Quidel Corporation’s (the “Company”) deferred compensation programs (including the employee bonus election form and the director fee payment election form), the Company hereby awards to you a Restricted |
|
| February 14, 2019 |
QDEL / QUIDEL Corp. / BROWN CAPITAL MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 8)* Quidel Corporation (Name of Issuer) Common Stock, Par Value $0.001 (Title of Class of Securities) 74838J101 (CUSIP Number) Eddie C. Brown Brown Capital Ma |
|
| February 13, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 13, 2019 QUIDEL CORPORATION (Exact name of registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-10961 (Commission File Number) 94 |
|
| February 13, 2019 |
QUIDEL REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] QUIDEL REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS SAN DIEGO, CA – (BusinessWire) - February 13, 2019 — Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutio |
|
| February 12, 2019 |
QDEL / QUIDEL Corp. / VANGUARD GROUP INC Passive Investment quidelcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5 )* Name of issuer: Quidel Corp Title of Class of Securities: Common Stock CUSIP Number: 74838J101 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appropriate box to designate |
|
| February 7, 2019 |
SC 13G/A 1 tv512656sc13ga.htm SCHEDULE 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Amendment No. 16 Under the Securities Exchange Act of 1934 Quidel Corp (Name of Issuer) Common Stock (Title of Class of Securities) 69404D108 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat |
|
| February 6, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 4, 2019 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Number) 94- |
|
| February 6, 2019 |
Exhibit 10.2 2019 Annual Equity Incentive Plan The 2019 Annual Equity Incentive Plan provides for the issuance of equity incentive awards in the form of (i) non-qualified stock options; (ii) time-based restricted stock units; and (iii) performance-based restricted stock units. Executive Officer Time-Based Restricted Stock Units (# shares) Performance-Based Restricted Stock Units (# shares) Non-Qua |
|
| February 6, 2019 |
2019 Cash Incentive Compensation Plan. Exhibit 10.1 2019 Cash Incentive Compensation Plan Eligible Employees: All non-Section 16 officers (“Vice Presidents”) and senior executives (Section 16) officers (“Executive Officers”) of the Company are eligible for participation in the Company’s 2019 Cash Incentive Compensation Plan. Applicable Period: The 2019 Cash Incentive Plan applies to performance during the Company’s fiscal year ending D |
|
| January 7, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 7, 2019 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-10961 (Commission File Number) 94-2 |
|
| January 7, 2019 |
QUIDEL ANNOUNCES PRELIMINARY REVENUE FOR FOURTH QUARTER 2018 Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] QUIDEL ANNOUNCES PRELIMINARY REVENUE FOR FOURTH QUARTER 2018 SAN DIEGO-(BUSINESS WIRE)-Jan 7, 2019- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellu |
|
| December 20, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 18, 2018 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-10961 (Commission File Number) 94 |
|
| December 18, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 12, 2018 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-10961 (Commission File Number) 94 |
|
| December 7, 2018 |
8-K 1 qdel8-kbeckmanmotionruling.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 7, 2018 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporat |
|
| December 7, 2018 |
QUIDEL COMMENTS ON CALIFORNIA COURT RULING Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer (858) 646-8023 (858) 552-7931 [email protected] QUIDEL COMMENTS ON CALIFORNIA COURT RULING SAN DIEGO-(BUSINESS WIRE)-Dec 7, 2018- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology |
|
| November 7, 2018 |
Exhibit 10.1 Publish CUSIP Number: 74839TAF5 AMENDED AND RESTATED CREDIT AGREEMENT Dated as of August 31, 2018 among QUIDEL CORPORATION as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, and The Other Lenders Party Hereto JPMORGAN CHASE BANK, N.A., as Syndication Agent BANK OF AMERICA MERRILL LYNCH and JPMORGAN CHASE BANK, N.A., as Joint Lead Arrange |
|
| November 7, 2018 |
QDEL / QUIDEL Corp. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-10961 QUIDEL |
|
| November 6, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2018 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Number) 94- |
|
| November 6, 2018 |
QUIDEL REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858. |
|
| September 4, 2018 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 31, 2018 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Number) 94-2 |
|
| August 8, 2018 |
QDEL / QUIDEL Corp. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-10961 QUIDEL CORPO |
|
| August 7, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 7, 2018 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Number) 94-25 |
|
| August 7, 2018 |
QUIDEL REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858. |
|
| June 1, 2018 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits 8-K 1 d586528d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 31, 2018 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 0-10961 94-2573850 (State or other jurisdiction of incorp |
|
| June 1, 2018 |
EX-10.1 Exhibit 10.1 Exchange Agreement May 31, 2018 Quidel Corporation 12544 High Bluff Drive, Suite 200 San Diego, California 92130 Attn: Randall J. Steward Re: Exchange of 3.25% Convertible Senior Notes due 2020 for Common Stock Ladies and Gentlemen: The undersigned investor (the “Investor”), for itself and on behalf of the beneficial owners listed on Exhibit B.1 hereto (“Accounts”) for whom th |
|
| May 30, 2018 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of Form SD. Exhibit 1.01 CONFLICT MINERALS REPORT For The Year Ended December 31, 2017 Introduction This Conflict Minerals Report (“Report”) of Quidel Corporation for the year ended December 31, 2017 is presented to comply with Rule 13p-1 under the Securities ExchanCMRge Act of 1934, as amended (“Rule”). Numerous terms in this Report are defined in Item 1.01 of Form SD promulgated under the Rule, and the read |
|
| May 30, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report QUIDEL CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 0-10961 94-2573850 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 12544 High Bluff Drive, Suite 200, San Diego CA 92130 (Address of Principal Executive |
|
| May 16, 2018 |
As filed with Securities and Exchange Commission on May 16, 2018 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 QUIDEL CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-2573850 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Id |
|
| May 16, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 15, 2018 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Number) 94-2573 |
|
| May 9, 2018 |
QDEL / QUIDEL Corp. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-10961 QUIDEL CORP |
|
| May 8, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 8, 2018 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Number) 94-25738 |
|
| May 8, 2018 |
QUIDEL REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS Exhibit Exhibit 99.1 |
|
| April 11, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Defin |
|
| April 4, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 29, 2018 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Number) 94-25 |
|
| March 9, 2018 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 8, 2018 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Number) 94-257 |
|
| March 9, 2018 |
Exhibit 10.1 Exchange Agreement March 8, 2018 Quidel Corporation 12544 High Bluff Drive, Suite 200 San Diego, California 92130 Attn: Randall J. Steward Re: Exchange of 3.25% Convertible Senior Notes due 2020 for Common Stock Ladies and Gentlemen: The undersigned investor (the “Investor”), for itself and on behalf of the beneficial owners listed on Exhibit B.1 hereto (“Accounts”) for whom the Inves |
|
| February 27, 2018 |
Subsidiaries of the Registrant. Exhibit 21.1* SUBSIDIARIES OF THE REGISTRANT Company State or Country of Organization Diagnostic Hybrids, Inc. Ohio Quidel Cardiovascular Inc. Delaware |
|
| February 27, 2018 |
Employment Offer Letter, dated October 16, 2017, between the Registrant and Ratan S. Borkar. Exhibit 10.33 [Quidel Letterhead] October 16, 2017 Ratan Borkar [Address] [Address] Dear Ratan: We are pleased to extend the following offer of employment to you: Title: Senior Vice President, International Commercial Operations Reporting to: Doug Bryant, President & CEO Compensation: $12,500.00 bi-weekly ($325,000 annualized) Annual Bonus: You will participate in the SVP bonus plan with a target |
|
| February 27, 2018 |
QDEL / QUIDEL Corp. 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from N/A to N/A Commission file number: 0-10961 QUIDEL C |
|
| February 27, 2018 |
Exhibit 10.34 AGREEMENT RE: CHANGE IN CONTROL This AGREEMENT RE: CHANGE IN CONTROL (this “Agreement”) is dated as of October 16, 2017 and is entered into by and between Ratan S. Borkar (“Executive”) and Quidel Corporation, a Delaware corporation (the “Company”). Background The Company believes that because of its position in the industry, financial resources and historical operating results there |
|
| February 27, 2018 |
Exhibit 10.29 - Publish CUSIP Number: 74839TAC2 Revolving Credit CUSIP Number: 74839TAD0 Term Loan CUSIP Number: 74839TAE8 CREDIT AGREEMENT Dated as of October 6, 2017 among QUIDEL CORPORATION as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, and The Other Lenders Party Hereto JPMORGAN CHASE BANK, N.A., as Syndication Agent BANK OF THE WEST, CITIBAN |
|
| February 26, 2018 |
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 26, 2018 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File N |
|
| February 21, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 21, 2018 QUIDEL CORPORATION (Exact name of registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-10961 (Commission File N |
|
| February 21, 2018 |
QUIDEL REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS Exhibit Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] QUIDEL REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS SAN DIEGO, CA ? (Marketwired) - February 21, 2018 ? Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing |
|
| February 14, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Amendment No. 15 Under the Securities Exchange Act of 1934 Quidel Corp (Name of Issuer) Common Stock (Title of Class of Securities) 69404D108 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| February 14, 2018 |
QDEL / QUIDEL Corp. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 7)* Quidel Corporation (Name of Issuer) Common Stock, Par Value $0.001 (Title of Class of Securities) 74838J101 (CUSIP Number) December 31, 2017 (Date of Eve |
|
| February 12, 2018 |
QDEL / QUIDEL Corp. / VANGUARD GROUP INC Passive Investment quidelcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4 )* Name of issuer: Quidel Corp Title of Class of Securities: Common Stock CUSIP Number: 74838J101 Date of Event Which Requires Filing of this Statement: December 31, 2017 Check the appropriate box to designate |
|
| February 9, 2018 |
QDEL / QUIDEL Corp. / SCHULER JACK W - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* QUIDEL CORPORATION (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 74838J101 (CUSIP Number) February 9, 2018 (Date of Event Which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to |
|
| February 2, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 29, 2018 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Number) 94- |
|
| January 22, 2018 |
2018 Cash Incentive Compensation Plan. Exhibit Exhibit 10.1 2018 Cash Incentive Compensation Plan Eligible Employees : All non-Section 16 officers (?Vice Presidents?) and senior executives (Section 16) officers (?Executive Officers?) of the Company are eligible for participation in the Company?s 2018 Cash Incentive Compensation Plan. Applicable Period : The 2018 Cash Incentive Plan applies to performance during the Company?s fiscal yea |
|
| January 22, 2018 |
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 16, 2018 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Nu |
|
| January 22, 2018 |
Exhibit Exhibit 10.2 2018 Annual Equity Incentive Plan The 2018 Annual Equity Incentive Plan provides for the issuance of equity incentive awards in the form of (i) non-qualified stock options; (ii) time-based restricted stock units; and (iii) performance-based restricted stock units. Executive Officer Time-Based Restricted Stock Units (# shares) Performance-Based Restricted Stock Units (# shares) |
|
| January 9, 2018 |
QDEL / QUIDEL Corp. 8-K (Current Report) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 5, 2018 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Num |
|
| January 9, 2018 |
Exhibit Exhibit 10.1 BUILDINGS C, D AND AMENITY CENTER LEASE AGREEMENT by and between ARE-SD REGION NO. 48 LLC , a Delaware limited liability company, as Landlord and QUIDEL CORPORATION , a Delaware corporation, as Tenant Dated as of January 5, 2018 TABLE OF CONTENTS 1. Premises, Parking Areas 1 2. Term 2 3. Renewal Options 2 4. Rent 3 5. Alterations 7 6. Use of Premises and Land; Compliance with |
|
| January 9, 2018 |
Exhibit Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer (858) 646-8023 (858) 552-7931 [email protected] QUIDEL COMPLETES SALE LEASEBACK OF SUMMERS RIDGE PROPERTY FOR $148.65 MILLION Generates more than $142 million in immediately available net cash proceeds SAN DIEGO, January 5, 2018 (Business Wir |
|
| December 19, 2017 |
Exhibit Exhibit 99.2 Triage MeterPro System and Triage BNP Test for Beckman Coulter Immunoassay System (Triage and BNP Product Lines or collectively the Product Lines of Alere, Inc.) Special Purpose Combined Statements of Assets Acquired and Liabilities Assumed as of September 30, 2017 (unaudited), December 31, 2016 and 2015. Special Purpose Combined Statements of Revenues and Direct Expenses for |
|
| December 19, 2017 |
Exhibit Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] Quidel Files Form 8-K/A, Reports Historical and Pro Forma Financial Information for Acquired Triage Assets and Combined Quidel and Triage Businesses SAN DIEGO, CA ? December 19, 2017 ? Quidel C |
|
| December 19, 2017 |
QDEL / QUIDEL Corp. 8-K/A (Current Report) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 6, 2017 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File N |
|
| December 19, 2017 |
QUIDEL CORPORATION UNAUDITED PRO FORMA COMBINED ABBREVIATED FINANCIAL INFORMATION Exhibit Exhibit 99.3 QUIDEL CORPORATION UNAUDITED PRO FORMA COMBINED ABBREVIATED FINANCIAL INFORMATION On October 6, 2017, Quidel Corporation and its subsidiaries (the "Company" or "Quidel") acquired the cardiovascular and toxicology Triage? MeterPro business (?Triage Business?) and Beckman Coulter Access Family of Immunoassay Systems (the ?BNP Business?) from Alere Inc. (collectively, the ?Triage |
|
| November 2, 2017 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| November 1, 2017 |
QUIDEL 8-K (Current Report/Significant Event) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 1, 2017 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Nu |
|
| November 1, 2017 |
QUIDEL REPORTS THIRD QUARTER 2017 FINANCIAL RESULTS Exhibit Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Angie Mazza Chief Financial Officer 312.690.6006 858.552.7931 [email protected] QUIDEL REPORTS THIRD QUARTER 2017 FINANCIAL RESULTS SAN DIEGO, CA ? November 1, 2017 ? Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virol |
|
| October 19, 2017 |
POWER OF ATTORNEY The undersigned hereby constitutes and appoints each of Douglas Bryant, Robert Bujarski, and Randall Steward, signing singly and not jointly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, any and all Forms 3, 4, and 5 (including any amendments thereto) required to be filed under Section 16(a) of the Securities Exchange Ac |
|
| October 10, 2017 |
QUIDEL QDEL AS OF 09/30/2017 (Passive Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 15) QUIDEL CORP (Name of Issuer) COMMON STOCK (Title of Class of Securities) 74838J101 (CUSIP Number) September 30, 2017 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is fil |
|
| October 6, 2017 |
Exhibit Exhibit 99.1 News Release Quidel Announces Closing of Acquisition of Alere Triage® Assets Creating an Expanded Portfolio of Rapid Diagnostic Capabilities in Critical Care Settings SAN DIEGO, CALIFORNIA – October 6, 2017 – Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced |
|
| October 6, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 6, 2017 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Number) 94-2 |
|
| September 18, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 15, 2017 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (Commission File Number) 9 |
|
| September 18, 2017 |
Exhibit 10.1 AMENDED AND RESTATED TRIAGE PURCHASE AGREEMENT by and among ALERE INC., QUIDEL CARDIOVASCULAR INC., for purposes of Sections 6.13 and 12.15, QUIDEL CORPORATION and for the limited purposes herein set forth, ABBOTT LABORATORIES Dated as of September 15, 2017 TABLE OF CONTENTS ARTICLE I DEFINITIONS 1 SECTION 1.01. Certain Defined Terms. 2 SECTION 1.02. Definitions. 11 SECTION 1.03. Inte |
|
| September 18, 2017 |
News Release Exhibit 99.1 Quidel Announces Revised Agreement for Its Pending Acquisition of Alere?s B-type Naturietic Peptide (BNP) Assay Business Run on Beckman Coulter Analyzers Revised agreement reflects Quidel?s direct commercial responsibility for all Beckman Coulter BNP sales globally, while the business arrangement for the pending acquisition of Alere?s Triage? MeterPro assets is substantia |
|
| September 18, 2017 |
Exhibit 10.2 AMENDED AND RESTATED PURCHASE AGREEMENT by and among ALERE INC., QUIDEL CARDIOVASCULAR, INC., for purposes of Section 11.15, QUIDEL CORPORATION and for the limited purposes herein set forth, ABBOTT LABORATORIES Dated as of September 15, 2017 TABLE OF CONTENTS ARTICLE I DEFINITIONS 1 SECTION 1.01. Certain Defined Terms. 1 SECTION 1.02. Definitions. 12 SECTION 1.03. Interpretation. 13 A |
|
| July 27, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0- |
|
| July 26, 2017 |
QUIDEL REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS Exhibit Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] QUIDEL REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS SAN DIEGO, CA ? (Marketwired) - July 26, 2017 ? Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellula |
|
| July 26, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 qdel-201706308xk.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 26, 2017 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 |
|
| July 17, 2017 |
Exhibit 10.1 TRIAGE PURCHASE AGREEMENT by and among ALERE INC., QTB ACQUISITION CORP., for purposes of Sections 6.13 and 12.15, QUIDEL CORPORATION and for the limited purposes herein set forth, ABBOTT LABORATORIES Dated as of July 15, 2017 TABLE OF CONTENTS ARTICLE I DEFINITIONS 1 SECTION 1.01. Certain Defined Terms. 1 SECTION 1.02. Definitions. 11 SECTION 1.03. Interpretation. 13 ARTICLE II PURCH |
|
| July 17, 2017 |
Exhibit 10.3 Merrill Lynch, Pierce, Fenner & Smith Incorporated Bank of America, N.A. JPMorgan Chase Bank, N.A. July 15, 2017 Quidel Corporation 12544 High Bluff Drive Suite 200 San Diego, California 92130 Attention: Randall J. Steward, Chief Financial Officer Project Temple Commitment Letter for $270 Million Senior Secured Credit Facilities Ladies and Gentlemen: Quidel Corporation (?you? or the ? |
|
| July 17, 2017 |
8-K 1 qdel71720178-k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 15, 2017 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation) 0-10961 (C |
|
| July 17, 2017 |
Exhibit 10.2 PURCHASE AGREEMENT by and among ALERE INC., QTB ACQUISITION CORP., for purposes of Section 11.15, QUIDEL CORPORATION and for the limited purposes herein set forth, ABBOTT LABORATORIES Dated as of July 15, 2017 TABLE OF CONTENTS ARTICLE I DEFINITIONS 1 SECTION 1.01. Certain Defined Terms. 1 SECTION 1.02. Definitions. 11 SECTION 1.03. Interpretation. 12 ARTICLE II PURCHASE AND SALE 13 S |
|
| July 17, 2017 |
Exhibit News Release Exhibit 99.1 Quidel Announces Definitive Agreement to Acquire Alere Triage ? Assets Combination creates an expanded, less seasonal portfolio of rapid diagnostic capabilities in critical care settings Transaction Highlights: ? Acquiring the assets of the Triage ? MeterPro cardiovascular and toxicology business, and the Triage BNP business from Alere Inc. ? Diversifies Quidel?s |
|
| May 31, 2017 |
CONFLICT MINERALS REPORT For The Year Ended December 31, 2016 Exhibit Exhibit 1.01 CONFLICT MINERALS REPORT For The Year Ended December 31, 2016 Introduction This Conflict Minerals Report (?Report?) of Quidel Corporation for the year ended December 31, 2016 is presented to comply with Rule 13p-1 under the Securities Exchange Act of 1934, as amended (?Rule?). Numerous terms in this Report are defined in Item 1.01 of Form SD promulgated under the Rule, and the |
|
| May 31, 2017 |
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report QUIDEL CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 0-10961 94-2573850 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 12544 High Bluff Drive, Suite 200, San Diego CA 92130 (Address of Principal E |
|
| May 17, 2017 |
QUIDEL 8-K (Current Report/Significant Event) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 16, 2017 QUIDEL CORPORATION (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 0-10961 (Commission File Number |
|
| May 17, 2017 |
QUIDEL COMPLETES ACQUISITION OF INFLAMMADRY® AND ADENOPLUS® EYE-HEALTH BUSINESSES Exhibit Exhibit 99.1 Quidel Contact: Media and Investors Contact: Quidel Corporation Quidel Corporation Randy Steward Ruben Argueta Chief Financial Officer 858.646.8023 858.552.7931 [email protected] QUIDEL COMPLETES ACQUISITION OF INFLAMMADRY? AND ADENOPLUS? EYE-HEALTH BUSINESSES SAN DIEGO, May 16, 2017 (MarketWired) - Quidel Corporation (NASDAQ: QDEL) , a provider of rapid diagnostic test |
|
| April 27, 2017 |
QUIDEL 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0 |
